Equities

Petmed Express Inc

Petmed Express Inc

Actions
Consumer Staples Personal Care, Drug and Grocery Stores
  • Price (USD)3.62
  • Today's Change-0.05 / -1.36%
  • Shares traded250.23k
  • 1 Year change-68.74%
  • Beta0.6865
Data delayed at least 15 minutes, as of Sep 18 2024 21:00 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Forecasts data is unavailable for this security.

Consensus recommendation

  • 14-Sep-23
  • 20-Jun-24
  • 18-Jul-24
  • 15-Aug-24
  • 12-Sep-24
Select bar for recommendation details.
Recommendations12-Sep-24
Buy0
Outperform0
Hold1
Sell1
Strong Sell0

Share price forecast in USD

The 2 analysts offering 12 month price targets for Petmed Express Inc have a median target of 3.50, with a high estimate of 3.50 and a low estimate of 3.50. The median estimate represents a -3.31% decrease from the last price of 3.62.
High-3.3%3.50
Med-3.3%3.50
Low-3.3%3.50

Dividends in USD

Dividend information is not available for Petmed Express Inc.
Div growth (TTM)-50.00%
More ▼

Earnings history & estimates in USD

On Aug 06, 2024, Petmed Express Inc reported 1st quarter 2025 earnings of 0.18 per share. This result exceeded the -0.09 consensus loss of the 2 analysts covering the company and outperformed last year's 1st quarter results by 0.22.
The next earnings announcement is expected on Oct 28, 2024.
Average growth rate-150.00%
Petmed Express Inc reported annual 2024 losses of -0.37 per share on Jun 11, 2024.
Average growth rate-37.60%
More ▼

Revenue history & estimates in USD

PetMed Express, Inc. had 1st quarter 2025 revenues of 67.95m. This missed the 75.00m estimate of the one analyst following the company. This was 13.15% below the prior year's 1st quarter results.
Average growth rate-3.32%
PetMed Express, Inc. had revenues for the full year 2024 of 281.06m. This was 9.42% above the prior year's results.
Average growth rate+0.16%
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.